At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...

The White House is reportedly considering former U.S. Rep. Michael Burgess (R-Texas) as its nominee to head the CDC. Burgess, ...

Adding the vaccine to treatment with Merck's Keytruda lowered melanoma patients' risk of ... With the exception of the ...

N.C.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to vaccine ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

Krahling was a published cancer researcher when vaccine maker Merck brought him on board as a virologist in 1999. That’s when he says he found himself embroiled in an all-hands-on-deck corporate ...

Merck (NYSE:MRK) experienced a 13% increase in its stock price over the last month, aided by several significant developments. The company's upcoming presentations at the American College of ...

The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.

She has received honoraria paid to her personally for participation in advisory boards for Gilead Sciences, Merck ... But, ...

“The effectiveness of the COVID vaccines can vary depending on which variants are targeted in the vaccine, which variants are circulating, and host factors,” said Shirin A. Mazumder, MD, and ...